11
Views
2
CrossRef citations to date
0
Altmetric
Original Article

BOMM Regimen for the Treatment of Advanced Head and Neck Carcinoma

, , &
Pages 485-489 | Published online: 11 Jun 2009

References

  • Ervin T. J., Weichselbaum R. R., Miller D., et al. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM). Cancer Treat Rep 1981; 65: 787–791
  • Adjuvant chemotherapy for head and neck squamous carcinoma. Cancer 1987; 60: 301–311, Final Report of the Head and Neck Contracts Program
  • Holoye P. Y., Grossman T. W., Twhil R. J., et al. Randomized study of adjuvant chemotherapy for head and neck cancer. Otolaryngol Head Neck Surg 1985; 93: 712–717
  • Hong W. K., Shapshay S. M., Bhutari R., et al. Induction chemotherapy in advanced squamous head and neck carcinoma with highdose cisplatinum and bleomycin infusion. Cancer 1979; 44: 19–25
  • Jacobs J. R., Pajak T. F., Kinzie J., et al. Induction chemotherapy in advanced head and neck cancer: A radiation therapy oncology group study. Arch Otolaryngol Head Neck Surg 1987; 113: 193–197
  • Kish J., Drelichman A., Jacobs J. R., et al. Clinical trial of cisplatinum and 5-fluorouracil as initial treatment for advanced squamous carcinoma of the head and neck. Cancer Treat Rep 1982; 66: 471–474
  • Kobo N., Inuyama Y., Mashima S., Horiuchi M. Combination chemotherapy for head and neck cancer. Japan J Otol Tokyo 1981; 84: 54–61
  • Pitman S. W., Kowal C. D., Bertino J. R. Methotrexate and 5-fluorouracil in sequence in squamous head and neck cancer. Semin Oncol 1983; 10((Suppl) 2)15–19
  • Price L. A., Hill B. T. A kinetidy based logical approach to the chemotherapy of head and neck cancer. Clin Otol 1977; 2: 339–345
  • Randolph V. L., Vallejo A., Spiro R. H., et al. Combination therapy of advanced head and neck cancer. Induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy. Cancer 1978; 41: 460–467
  • Schuller D. E., Wilson H., Hodgson S. Preoperative reductive chemotherapy for Stage III or IV operable epidermal carcinoma of the oral cavity, oropharynx, hypopharynx or larynx: Phase III. A Southwest Oncology Group Study (Abstr). Proc Int Conf Head Neck Cancer 1984; 1: 48
  • Spaulding M. B., Kahn A., De Los Santos R., et al. Adjuvant chemotheapy in advanced head and neck cancer. Am J Surg 1982; 144: 432–436
  • Sridhar K. S., Ohnuma T., Biller H., et al. Combination chemothempy with high dose methotrexate, bleomycin and cisplatin in the management of head and neck carcinoma. Am J Clin Oncol (CCV) 1985; 8: 55–60
  • Vogl S. E., Kaplan B. H. Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin and cis-diaxnminedichloro-platinum (II) in an effective outpatient schedule. Cancer 1979; 44: 26–31
  • Vogl S. E., Schoenfeld D. A., Kaplan B. H., et al. A randomized prospective comparison of methotrexate with a combination of mthotrexate, bleomycin and cis-platinum in head and neck cancer. Cancer 1985; 56: 432–442
  • Wittes R., Heller K., Randolph V., et al. Cis-dichlorodiammineplatinum (11) -based chemothexapy as initial treatment of advanced head and neck cancer. Cancer Treat Rep 1979; 63: 1533–1538
  • Crooke S. T., Bradner W. T. Mitomycin-C: A review. Cancer Treat Rev 1976; 3: 121–129
  • Gupta V., Costanz J. J. Role of hypoxia in anticancer drug-induced cytotoxicity for Ehrlich ascites cells. Cancer Res 1987; 47: 2407–2412
  • Sartorelli A. C. Therapeutic attack of hypoxic cells of solid tumors: Presidential address. Cancer Res 1988; 48: 775–78
  • Jacobs J. R., Al-Sarraf M. Combined modality therapy utilizing a cisplatin combination for effective chemotherapy in patients with previously untreated head and neck carcinoma. Am J Sur 1986; 152: 451–455
  • Molinari R., Mattavelli F., Gantu G., et al. Results of a low-dose combination chemotherapy with vincristine, bleomycin and methotrexate (V-B-M) based on cell kinetics in the Native treatment of head and neck squamous cell carcinoma. Eur J Cancer 1980; 16: 469–472
  • Smith R. E., Heilbrun L. K., Bottomley R. M., et al. Therapy of recurrent squamous cell carcinoma of the head and neck using combination vincristine, bleomycin and methotrexate. Cancer 1986; 58: 2382–2385
  • Leyvraz S., Barrelet L., Savary M., Bernascon S. Combination of xnitomycin and cisplatin in the treatment of head and neck squamous cell carcinoma. Cancer Treat Rep 1987; 71: 81–82

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.